Literature DB >> 12800109

No influence of the PPARgamma2 Pro12Ala genotype on serum adiponectin concentrations in healthy Europeans.

Claus Thamer, Fausto Machicao, Andreas Fritsche, Michael Stumvoll, Hans Häring.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12800109     DOI: 10.1016/s0026-0495(03)00080-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  5 in total

1.  The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.

Authors:  G D Tan; M J Neville; E Liverani; S M Humphreys; J M Currie; L Dennis; B A Fielding; F Karpe
Journal:  Diabetologia       Date:  2005-12-17       Impact factor: 10.122

2.  Influence of different CLA isomers on insulin resistance and adipocytokines in pre-diabetic, middle-aged men with PPARγ2 Pro12Ala polymorphism.

Authors:  Diana Rubin; Julia Herrmann; Daniela Much; Maria Pfeuffer; C Laue; P Winkler; Ulf Helwig; Doris Bell; Annegret Auinger; Stephanie Darabaneanu; Andreas Ruether; Jürgen Schrezenmeir
Journal:  Genes Nutr       Date:  2012-03-08       Impact factor: 5.523

Review 3.  Human genetics of adiponectin in the metabolic syndrome.

Authors:  Wei-Shiung Yang; Lee-Ming Chuang
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

4.  Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity.

Authors:  F Vasseur; N Helbecque; S Lobbens; V Vasseur-Delannoy; C Dina; K Clément; P Boutin; T Kadowaki; P E Scherer; P Froguel
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

5.  Effect of the Pro12Ala polymorphism of the PPARg2 gene on serum adiponectin changes.

Authors:  Firoozeh Mousavinasab; Tuula Tähtinen; Jari Jokelainen; Pentti Koskela; Mauno Vanhala; Jorma Oikarinen; Sirkka Keinänen-Kiukaanniemi; Markku Laakso
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.